
    
      This will be a longitudinal addition to an existing R21cohort enrolled in the first trimester
      to include a first and third trimester assessment of pharmacokinetics/pharmacodynamics
      (PK/PD) of aspirin and how individual factors impact aspirin PK/PD in pregnancy.
    
  